Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

892
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
892
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation Oncology-Biology Integration Network: Bridging the Gap between Biological Research and Clinical Practice.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming.

Cancer discovery·2025
Same author

Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis.

Nature·2025
Same author

Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function.

The Journal of experimental medicine·2025
Same author

Amphiregulin as a Mediator of Radiation-Induced Systemic Effects in Metastatic Cancer: Balancing Local Control with Distant Progression.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.

Nature·2025

Related Experiment Video

Updated: Jun 25, 2025

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

812

Radiotherapy and immunology.

Liangliang Wang1,2, Connor Lynch1,2, Sean P Pitroda1,2

  • 1Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.

The Journal of Experimental Medicine
|May 21, 2024
PubMed
Summary
This summary is machine-generated.

Radiotherapy impacts cancer treatment by modulating the immune system. Understanding this balance of immune activation and suppression is key to improving radiotherapy efficacy.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

325
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Related Experiment Videos

Last Updated: Jun 25, 2025

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

812
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

325
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Area of Science:

  • Oncology
  • Immunology
  • Radiotherapy Research

Background:

  • Radiotherapy is a cornerstone of cancer treatment, historically focused on DNA damage.
  • Recent research highlights the significant role of the immune system in radiotherapy's anti-tumor effects.
  • Radiotherapy influences both pro-tumor and anti-tumor immune responses within the tumor microenvironment.

Purpose of the Study:

  • To review the dual role of the immune system in radiotherapy-induced anti-tumor effects.
  • To explore how radiotherapy reprograms the tumor microenvironment to modulate immunity.
  • To summarize clinical trials combining radiotherapy with immune checkpoint inhibitors.

Main Methods:

  • Review of current literature on radiotherapy and its immunomodulatory effects.
  • Analysis of mechanisms by which radiotherapy activates or suppresses anti-tumor immunity.
  • Compilation and review of clinical trial data for radiotherapy combined with PD-1/PD-L1 and CTLA-4 blockade.

Main Results:

  • Radiotherapy activates innate and adaptive immunity via DNA/RNA sensing pathways.
  • Radiotherapy can also suppress anti-tumor immunity through recruitment of regulatory cells.
  • The interplay between pro- and anti-tumor immunity is mediated by cytokines and chemokines.
  • Microbiota composition can influence radiotherapy outcomes.
  • Combination of radiotherapy with immune checkpoint inhibitors (PD-1/PD-L1, CTLA-4) is under extensive clinical investigation.

Conclusions:

  • Radiotherapy exerts complex effects on the anti-tumor immune response, involving both activation and suppression.
  • Modulating the immune microenvironment and considering factors like microbiota are crucial for optimizing radiotherapy.
  • Clinical trials investigating immune checkpoint blockade with radiotherapy show promise for enhancing treatment efficacy.